Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
7.50M
Dividend Yield
0.00%
P/E Ratio
-1.76
EPS
-2.64
Revenue
1.29M
Avg. Volume
126.23K

Recently from Cashu

publisher logo
Cashu

Aptorum Group: Key Developments and Updates on Business Progress and Future Plans

6 days ago
publisher logo
Cashu

Aptorum Group Advances SACT-1: A Novel Antibiotic Against Resistant Infections

8 days ago
publisher logo
Cashu

Aptorum Group: Innovative Developments and Future Prospects in Healthcare Solutions.

13 days ago

About

What does APM do?
Aptorum Group is a pharmaceutical company focused on developing therapies for unmet medical needs, with key projects including ALS4, SACT-1, and the PathsDx Test. ALS4 targets harmful bacterial gene products, while SACT-1 is a repurposed drug candidate.
Sector
💻 Health Care
IPO
CEO
Employees
3 employees
Headquarters
China
Website
http://www.aptorumgroup.com
Stocks
Health Care
apm
Aptorum Group
NASDAQ: APM
-0.14 (-9.03%)
1.41
USD
At close at Aug 01, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials